AVORISA Trademark

Trademark Overview

On Monday, January 25, 2021, a trademark application was filed for AVORISA with the United States Patent and Trademark Office. The USPTO has given the AVORISA trademark a serial number of 90486194. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, January 25, 2024. This trademark is owned by Axsome Therapeutics, Inc.. The AVORISA trademark is filed in the Pharmaceutical Products category with the following description:

Prescription medicines for the treatment of migraines
avorisa

General Information

Serial Number90486194
Word MarkAVORISA
Filing DateMonday, January 25, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, January 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2021

Trademark Statements

Goods and ServicesPrescription medicines for the treatment of migraines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAxsome Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
Party NameAxsome Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10038

Trademark Events

Event DateEvent Description
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024SOU EXTENSION 5 GRANTED
Tuesday, January 9, 2024SOU EXTENSION 5 FILED
Thursday, January 25, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2023SOU EXTENSION 4 GRANTED
Thursday, July 6, 2023SOU EXTENSION 4 FILED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023SOU EXTENSION 3 GRANTED
Wednesday, March 29, 2023SOU EXTENSION 3 FILED
Wednesday, March 29, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 29, 2022SOU EXTENSION 2 GRANTED
Wednesday, June 29, 2022SOU EXTENSION 2 FILED
Wednesday, June 29, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, March 13, 2022SOU EXTENSION 1 GRANTED
Sunday, March 13, 2022SOU EXTENSION 1 FILED
Sunday, March 13, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 10, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 10, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 24, 2021ASSIGNED TO EXAMINER
Monday, April 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 28, 2021NEW APPLICATION ENTERED

Related Keywords

avorisa migraines treatment medicines prescription